To further validate the expression levels of G6PD, SIRT2, PER2 in GBM cell lines and explore the interaction among G6PD, SIRT2, PER2, and metformin, we detected the expression of these indicators dynamically during 24h in the condition of metformin intervention or without (Figure 5A). The gene discussed is PER2; the disease is glioblastoma.